SLV 311
Latest Information Update: 19 Dec 2006
At a glance
- Originator Solvay
- Class Irritable bowel syndrome therapies
- Mechanism of Action Motilin stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Gastrointestinal disorders